Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and
Sonja Hinz1,2, Dominik Jung1, Dorota Hauert1
1Center for Biomedical Education and Research (ZBAF), Faculty of Health, Institute of Pharmacology and Toxicology, School of Medicine, University of Witten/Herdecke, 58453 Witten, Germany.
Abstract:
Geranylgeranyltransferase type-I (GGTase-I) represents an important drug target since it contributes to the function of many proteins that are involved in tumor development and metastasis. This led to the development of GGTase-I inhibitors as anti-cancer drugs blocking the protein function and membrane association of e.g., Rap subfamilies that are involved in cell differentiation and cell growth. In the present study, we developed a new NanoBiT assay to monitor the interaction of human GGTase-I and its substrate Rap1B. Different Rap1B prenylation-deficient mutants (C181G, C181S, and ΔCQLL) were designed and investigated for their interaction with GGTase-I. While the Rap1B mutants C181G and C181S still exhibited interaction with human GGTase-I, mutant ΔCQLL, lacking the entire CAAX motif (defined by a cysteine residue, two aliphatic residues, and the C-terminal residue), showed reduced interaction. Moreover, a specific, peptidomimetic and competitive CAAX inhibitor was able to block the interaction of Rap1B with GGTase-I. Furthermore, activation of both Gαs-coupled human adenosine receptors, A2A (A2AAR) and A2B (A2BAR), increased the interaction between GGTase-I and Rap1B, probably representing a way to modulate prenylation and function of Rap1B. Thus, A2AAR and A2BAR antagonists might be promising candidates for therapeutic intervention for different types of cancer that overexpress Rap1B. Finally, the NanoBiT assay provides a tool to investigate the pharmacology of GGTase-I inhibitors.
Insights
Researchers developed a NanoBiT assay to study geranylgeranyltransferase type-I (GGTase-I) and its substrate Rap1B. This assay helps investigate GGTase-I inhibitors for cancer therapy by analyzing Rap1B interactions.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Geranylgeranyltransferase type-I (GGTase-I) is crucial for tumor development and metastasis.
- GGTase-I inhibitors are developed as anti-cancer drugs targeting protein function and membrane association.
- Rap subfamilies, like Rap1B, are involved in cell differentiation and growth, making them key targets.
Purpose of the Study:
- To develop a novel NanoBiT assay for monitoring the interaction between human GGTase-I and its substrate Rap1B.
- To investigate the impact of Rap1B prenylation-deficient mutants on GGTase-I interaction.
- To explore the role of adenosine receptors in modulating GGTase-I and Rap1B interaction.
Main Methods:
- Development of a NanoBiT assay to quantify GGTase-I and Rap1B interactions.
- Design and analysis of Rap1B prenylation-deficient mutants (C181G, C181S, ΔCQLL).
- Investigation of the effect of adenosine receptor activation (A2AAR, A2BAR) on GGTase-I/Rap1B interaction.
Main Results:
- The NanoBiT assay successfully monitored GGTase-I and Rap1B interactions.
- Rap1B mutants C181G and C181S showed interaction with GGTase-I, while ΔCQLL exhibited reduced interaction due to CAAX motif deletion.
- A CAAX inhibitor blocked Rap1B-GGTase-I interaction, and adenosine receptor activation enhanced it.
Conclusions:
- The NanoBiT assay is a valuable tool for studying GGTase-I inhibitor pharmacology.
- Adenosine receptors A2AAR and A2BAR activation modulate Rap1B prenylation and function.
- A2AAR and A2BAR antagonists represent potential therapeutic strategies for Rap1B-overexpressing cancers.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Activation and Inactivation of G Proteins
GTPases and their Regulation
Large G-proteins,...
MAPK Signaling Cascades


